Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Malaysia | en

Choose Location

  • International
  • Americas
  • Europe
  • Middle East & Africa
  • Asia Pacific
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Argentina | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Latin America | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Egypt | en
  • South Africa | en
  • Turkey | tr
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh

Language & Country Selector for Mobile

language-selector-globe my

Choose Location

International Americas Europe Middle East & Africa Asia Pacific
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latin America | es
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Sandoz | en
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About
      • Novartis in Malaysia
      • Strategy
      • Diversity and Inclusion
      • People and Culture
      • Products
      • Country Leadership Team
      • Diversity and Inclusion
      • Our Business
      • Novartis Mission & Vision
      About
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Diseases
      • Adverse Event Reporting
      • Our Process
      Patients and Caregivers
    • Healthcare Professionals
      • Healthcare professional country resource
      • Novartis Pipeline
      • Adverse Event Reporting
      • Novartis Clinical Trials
      • Therapeutic Areas
      Healthcare Professionals
    • ESG
      • Ethical Behavior
        • Code of Ethics
        • SpeakUp
      • Ethics, Risk and Compliance
      • Access
      • Environmental Sustainability
      • Global Health
      ESG
    • News
      • Stories
      • News Archive
      • Contacts
      News
    • Careers
      • Career Search
      • Meet the teams
      • Personal Growth
      • Early Talent
      • How We Work
      • Well-being
      • Awards and Recognition
      Careers
    • Coronavirus
    • Contact
    Home
  1. Home
  2. News
  3. News Archive

News Archive

News Archive Navigation
  • All
icon

April 2022

  • In The NewsApr 28, 2022
    Novartis Malaysia assures easy access to treatments to Malaysian frontliners, at-risk communities
  • In The NewsApr 28, 2022
    https://focusmalaysia.my/how-novartis-malaysia-exudes-top-employer-qualities-across-its-operations/
  • In The NewsApr 28, 2022
    Novartis Contributed US$273 Million To Malaysia’s Economy In 2020
  • StoryApr 20, 2022
    Sneak Peek of Novartis Malaysia's New Office

February 2022

  • Media ReleaseFeb 28, 2022
    Novartis Malaysia wins Top Employer 2022 for 3rd Year in a Row
    Kuala Lumpur, February 10, 2022 - Leading medicines company Novartis Malaysia is recognized as Top Employer 2022 for the third consecutive year. The organization clinched a double feat with this…

January 2022

  • Media ReleaseJan 15, 2022
    Novartis Malaysia keeps Malaysians safe through Covid-19 pandemic
    Kuala Lumpur, December 15, 2021 - As a leading medicines company, Novartis Malaysia’s purpose is to help 32 million Malaysians live longer and happier by ensuring access of treatments to patients…

November 2021

  • StoryNov 23, 2021 Education and Awareness
    Improved Survival for Advanced Breast Cancer Patients

February 2021

  • Media ReleaseFeb 24, 2021
    Non-Communicable Diseases in the New Normal
    Novartis educates susceptible COVID-19 groups on lifestyle changes amid the coronavirus pandemic Kuala Lumpur, 21 January 2020 – NCDs are estimated to account for 74% of all deaths in Malaysia1 .…

August 2020

  • Media ReleaseAug 10, 2020
    Novartis Malaysia bags LIFE AT WORK 2019 Award for Outstanding Practice from TalentCorp
    Kuala Lumpur, Malaysia, 10 August 2020 – Novartis Malaysia, a leading global medicines company with over 40 years presence in Malaysia, was recently awarded TalentCorp’s LIFE AT WORK 2019 AWARD for…

April 2020

  • Media ReleaseApr 27, 2020
    Novartis Malaysia announces broad range of initiatives to support the government in the fight against the COVID-19 pandemic
    RM1million contribution in partnership with MERCY Malaysia for personal protection equipment (PPE) for healthcare workers in 27 government hospitals nationwide Donation of 10,000 hand sanitizers for…

March 2020

  • Featured NewsMar 30, 2020
    Novartis COVID-19 Information Center

December 2019

  • StoryDec 06, 2019 Hope
    #BePsoPositive in support of Psoriasis Patients

Pagination

  • 1
  • 2
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2022 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia